The board of directors of Pfizer Inc. today declared a 28-cent
fourth-quarter 2015 dividend on the company’s common stock, payable
December 1, 2015, to shareholders of record at the close of business on
November 6, 2015. The fourth-quarter 2015 cash dividend will be the 308th
consecutive quarterly dividend paid by Pfizer.
About Pfizer Inc.
At Pfizer, we apply science and our global resources to bring therapies
to people that extend and significantly improve their lives. We strive
to set the standard for quality, safety and value in the discovery,
development and manufacture of health care products. Our global
portfolio includes medicines and vaccines as well as many of the world's
best-known consumer health care products. Every day, Pfizer colleagues
work across developed and emerging markets to advance wellness,
prevention, treatments and cures that challenge the most feared diseases
of our time. Consistent with our responsibility as one of the world's
premier innovative biopharmaceutical companies, we collaborate with
health care providers, governments and local communities to support and
expand access to reliable, affordable health care around the world. For
more than 150 years, Pfizer has worked to make a difference for all who
rely on us. To learn more, please visit us at www.pfizer.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150925005458/en/
Copyright Business Wire 2015